Estrogen plus progestin and the risk of peripheral arterial disease

被引：1
|
作者：
Hsia, J [1 ]
Criqui, M [1 ]
Rodabough, R [1 ]
Resnick, H [1 ]
Kotchen, J [1 ]
Bonds, D [1 ]
Allison, M [1 ]
Caralis, P [1 ]
Phillips, L [1 ]
Masaki, K [1 ]
Langer, RD [1 ]
机构：
[1] George Washington Univ, Washington, DC USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2004年 / 43卷 / 05期
关键词：
D O I：
10.1016/S0735-1097(04)92185-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：516A / 516A
页数：1
相关论文
共 50 条
  • [21] Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
    Trabert, Britton
    Wentzensen, Nicolas
    Yang, Hannah P.
    Sherman, Mark E.
    Hollenbeck, Albert R.
    Park, Yikyung
    Brinton, Louise A.
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (02) : 417 - 426
  • [22] Use of estrogen plus progestin is associated with greater increase in breast cancer risk than estrogen alone.
    Colditz, G
    Rosner, B
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1998, 147 (11) : S64 - S64
  • [23] Unfavorable risk: benefit ratio with antiplatelet plus anticoagulant therapy for peripheral arterial disease
    不详
    FORMULARY, 2007, 42 (11) : 648 - +
  • [24] Re: Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin - Response
    Pike, MC
    Ross, RK
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (23) : 1951 - 1952
  • [25] Re: Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin - Response
    Ross, RK
    Pike, VC
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (13) : 1100 - 1101
  • [26] More about: Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
    Magnusson, C
    Persson, I
    Adami, HO
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (14) : 1183 - 1184
  • [27] EFFECTS OF ESTROGEN OR ESTROGEN/PROGESTIN REGIMENS ON HEART-DISEASE RISK-FACTORS IN POSTMENOPAUSAL WOMEN - THE POSTMENOPAUSAL ESTROGEN/PROGESTIN INTERVENTIONS (PEPI) TRIAL
    MILLER, VT
    LAROSA, J
    BARNABEI, V
    KESSLER, C
    LEVIN, G
    SMITHROTH, A
    GRIFFIN, M
    STOY, DB
    BUSH, T
    ZACUR, H
    FOSTER, D
    ANDERSON, J
    MCKENZIE, A
    MILLER, S
    WOOD, PD
    STEFANICK, ML
    MARCUS, R
    AKANA, A
    HEINRICHS, L
    KIRCHNER, C
    OHANLAN, K
    RUYLE, M
    SHEEHAN, M
    JUDD, HL
    GREENDALE, G
    BAYALOS, R
    LOZANO, K
    KAWAKAMI, K
    BARRETTCONNOR, E
    LANGER, R
    KRITZSILVERSTEIN, D
    CARRIONPETERSEN, ML
    CAVERO, C
    SCHROTT, HG
    JOHNSON, SR
    FEDDERSEN, DA
    KRUTZFELDT, DL
    BENDA, JA
    PAUERSTEIN, C
    TRABAL, J
    SCHENKEN, R
    STERN, MP
    RODRIGUEZSIFUENTES, M
    EASTON, C
    WELLS, HB
    ESPELAND, M
    HOWARD, G
    BYINGTON, R
    LEGAULT, C
    SHUMAKER, S
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (03): : 199 - 208
  • [28] ESTROGEN PLUS PROGESTIN IN POST-MENOPAUSAL WOMEN
    MACDONALD, PC
    NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (27): : 1644 - 1645
  • [29] Estrogen plus progestin may increase incidence of dementia
    Culhane, NS
    JOURNAL OF FAMILY PRACTICE, 2003, 52 (10): : 754 - +
  • [30] Estrogen plus progestin and colorectal cancer in postmenopausal women
    Grant, ECG
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23): : 2417 - 2418
12345